Vulvodynia: Chronic Vulvar Pain Without a Visible Cause
Vulvodynia is defined as vulvar pain, burning, or discomfort lasting at least 3 months, with no identifiable cause on examination (no infection, dermatosis, neoplasm, or specific neurological disease). It affects 10–28% of women at some point in life, with a devastating impact on sexual quality of life, mental health, and relationships. It is chronically underdiagnosed — women with vulvodynia consult an average of 3–5 different professionals before the correct diagnosis.
The pathophysiology of vulvodynia involves: small fiber neuropathy(increased C-fiber density in the vestibular epithelium); central sensitization (increased excitability at the S2–S4 spinal level); and autonomic nervous system imbalance (sympathetic hyperactivity that maintains a state of pelvic hypervigilance). The amygdala and anterior cingulate cortex — regions of fear processing — are hyperactive on neuroimaging in women with vestibulodynia.
Conventional Treatments: Multimodal by Necessity
No single treatment is effective for all cases of vulvodynia. The multimodal approach — combining pharmacological, local, behavioral, and physical interventions — has the best response rate. Long-term studies show that most patients improve with adequate treatment, but a year or more may be needed for optimal results.
THERAPEUTIC OPTIONS IN VULVODYNIA
| TREATMENT | EFFICACY | LIMITATIONS |
|---|---|---|
| Amitriptyline 10–75 mg/day (oral) | 50–60% reduction in spontaneous pain; less effective in provoked vestibulodynia | Drowsiness, dry mouth, weight gain; effective dose often causes unacceptable sedation |
| Gabapentin 900–3,600 mg/day | Effective in small fiber neuropathy and pudendal neuralgia | Dizziness, drowsiness, weight gain; limited tolerability in active young women |
| Topical lidocaine 5% (overnight use) | Reduces allodynia on the cotton-swab test; improves tolerance to dilators and intercourse | Temporary effect; does not modify the central process |
| Pelvic physical therapy | Reduction of levator spasm, improvement of sexual function; highly effective for associated vaginismus | Cost; limited availability; slow progression |
| Vestibulectomy (refractory vestibulodynia) | Significant improvement in 60–70% of refractory provoked vestibulodynia | Surgery; not indicated for generalized vulvodynia; risk of adhesions |
| Acupuncture | VAS −3.3 pts and peripheral desensitization on QST described in modest-sized studies; no pharmacological interactions described with amitriptyline/gabapentin | Access and cost; requires 10–12 sessions for response; moderate quality evidence |
How Acupuncture Works in Vulvodynia
Mechanisms in Vulvodynia
Neuromodulation of Pudendal C-Fibers
BL-32 and BL-33 at the S2–S3 sacral foramina directly stimulate the roots that give rise to the pudendal nerve. EA at 2 Hz at this level reduces the ectopic discharge of hypersensitized C-fibers in the vestibule. QST objectively documents an increase in the heat pain threshold (+2.1°C) after 10 sessions — indicative of real peripheral desensitization.
Modulation of Spinal Central Sensitization
Generalized vulvodynia has a dominant central component: the S2–S4 dorsal horn amplifies all pelvic stimuli. Acupuncture reduces NMDA-R and c-fos expression in the dorsal horn, progressively reversing spinal hypersensitivity. A slow process (weeks to months) but sustained.
Normalization of Pelvic Floor Tone
SP-6 and BL-36 activate the inhibitory spino-bulbo-spinal reflex pathway of the pubococcygeus and levator ani muscles. Pelvic floor hypertonia — present in 80% of women with vulvodynia — maintains a state of local nociceptive alertness that acupuncture progressively normalizes.
Emotional Modulation via the Amygdala
GV-20 and HT-7 activate the descending serotonergic pathway and reduce amygdala hyperactivity documented on fMRI. Pain catastrophizing — the main predictor of worse prognosis in vulvodynia — improves with 8–12 weeks of acupuncture, possibly through modulation of the amygdala-prefrontal cortex axis.
Main Points
BL32–BL33 — Sacral Neuromodulation
S2–S3 foramina: the most direct access point to the pudendal nerve. EA at 2 Hz produces neuromodulation with documented effect on QST. Requires a physician with anatomical knowledge for correct positioning in the foramina.
SP6 + LR5 — Pelvic Floor Regulation
SP6 and LR5 form the complementary pair for the lower pelvic region. Classic combination for vulvodynia in medical acupuncture.
CV3 + CV4 — Uterovesical Convergence
CV3 is described in the tradition of Chinese medicine as a crossing point with the bladder channel (useful when associated interstitial cystitis is present — frequent in generalized vulvodynia); biomedically, it acts on the inferior hypogastric plexus. CV4, in the Chinese tradition associated with uterine Qi and the pelvic floor, corresponds to a territory innervated by sympathetic and parasympathetic branches of the pelvic plexus.
Scientific Evidence
Modern Approach: Acupuncture in the Multimodal Plan
Enhances Pelvic Physical Therapy
Pelvic physical therapy with progressive dilators tends to be better tolerated when hypertonia and hypervigilance are reduced. A frequently used sequence in practice: acupuncture for desensitization → physical therapy for pelvic floor reeducation. Exact comparative benefits still require more controlled clinical trials.
When to See a Medical Acupuncturist
Indications
Vulvodynia with diagnosis established by a gynecologist or dermatologist; failure or intolerance to amitriptyline/gabapentin; as a complement to pelvic physical therapy; vestibulodynia awaiting surgical evaluation (improves quality of life during the waiting period).
Expectation
Initial response expected in 6–8 sessions (QST improves by 10 sessions). Sustained clinical improvement after 12 weeks. Vulvodynia requires maintenance treatment — biweekly or monthly sessions after the intensive phase.
Frequently Asked Questions
Frequently Asked Questions
Needling is performed at points distant from the vulva (leg, sacrum, wrist, head) — not in the painful area. The 0.20 mm needles produce a tolerable sensation of heaviness or tingling. At sacral BL-32, EA may produce radiation to the perineum — this is expected and indicates good localization, but it can be reduced if uncomfortable. The physician adjusts the intensity according to individual tolerance.
The active treatment phase typically lasts 10–16 weekly sessions. The response is progressive: first signs of improvement at 4–6 weeks, with more complete results at 12 weeks. After the active phase, biweekly or monthly maintenance sessions prevent recurrence. Vulvodynia tends to recur without maintenance — long-term planning is necessary.
Not necessarily. Vestibulectomy has a 60–70% success rate in refractory provoked vestibulodynia — it is a valid procedure for selected cases. Acupuncture can be tried before surgery to assess the response to conservative desensitization. In cases of insufficient response after 12–16 weeks of acupuncture + physical therapy, vestibulectomy should be evaluated together with the gynecologist.
Yes — and this is one of the situations where acupuncture is most valuable. Vulvodynia and interstitial cystitis belong to the same spectrum of central pelvic sensitization. The BL-32–BL-33 (sacral), CV-3 (bladder-uterus crossing), and SP-6 protocol addresses both conditions through a common mechanism: neuromodulation of the S2–S4 roots that govern all pelvic sensation and function.